ERBB2 and breast carcinoma: ER showed excellent concordance, whereas PR demonstrated moderate agreement.<h4>Conclusions</h4>FNAC-derived CBs are a reliable tool for identifying HER2-low breast carcinomas when histological samples are unavailable or limited, emphasizing the need for standardized evaluation criteria.